Imaging of Solid Tumors Using FAP-2286
Latest Information Update: 18 Sep 2023
At a glance
- Drugs Gallium-68 FAP 2286-Clovis Oncology (Primary)
- Indications Adenocarcinoma; Advanced breast cancer; Bladder cancer; Colon cancer; Head and neck cancer; Male breast cancer; Pancreatic cancer; Prostate cancer; Sarcoma; Solid tumours
- Focus Adverse reactions; Diagnostic use; First in man
- 12 Sep 2023 Planned number of patients changed from 86 to 116.
- 15 Aug 2023 Planned End Date changed from 30 Jun 2023 to 30 Jun 2024.
- 15 Aug 2023 Planned primary completion date changed from 30 Jun 2023 to 30 Jun 2024.